Published in Int J Food Microbiol on March 25, 2003
Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol (2010) 1.20
VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation. Can J Gastroenterol (2008) 0.93
Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects. Urol Res (2010) 0.93
Survival of yogurt bacteria in the human gut. Appl Environ Microbiol (2006) 0.91
Congruent strain specific intestinal persistence of Lactobacillus plantarum in an intestine-mimicking in vitro system and in human volunteers. PLoS One (2012) 0.83
p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis. Korean J Pediatr (2013) 0.78
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology (2003) 4.40
Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics (2010) 3.43
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. J Antimicrob Chemother (2010) 1.79
Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl Environ Microbiol (2005) 1.64
Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol (2003) 1.51
Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance. Int J Radiat Oncol Biol Phys (2008) 1.45
Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol (2005) 1.40
Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis. J Biol Chem (2005) 1.23
Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bowel Dis (2009) 1.16
Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis (2002) 1.15
Bacterial vaginosis: a review on clinical trials with probiotics. New Microbiol (2013) 1.14
Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case. Mol Cell Proteomics (2012) 1.13
Antimicrobial and antitumor activity of N-heteroimmine-1,2,3-dithiazoles and their transformation in triazolo-, imidazo-, and pyrazolopirimidines. Bioorg Med Chem (2002) 1.13
Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by (1)H Nuclear Magnetic Resonance spectroscopy. Int J Food Microbiol (2009) 1.12
High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum (2007) 1.12
Single cell oils of the cold-adapted oleaginous yeast Rhodotorula glacialis DBVPG 4785. Microb Cell Fact (2010) 1.11
Folate production by bifidobacteria as a potential probiotic property. Appl Environ Microbiol (2006) 1.08
Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants. BMC Microbiol (2011) 1.06
Bifidobacterial enolase, a cell surface receptor for human plasminogen involved in the interaction with the host. Microbiology (2009) 1.04
Binding of human plasminogen to Bifidobacterium. J Bacteriol (2007) 1.02
High taxonomic level fingerprint of the human intestinal microbiota by ligase detection reaction--universal array approach. BMC Microbiol (2010) 1.01
Real-time PCR quantification of bacterial adhesion to Caco-2 cells: competition between bifidobacteria and enteropathogens. Res Microbiol (2005) 1.00
Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities. Appl Microbiol Biotechnol (2012) 0.97
Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: impact of acidic conditions on the transcriptional levels of the oxalyl coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes. Appl Environ Microbiol (2010) 0.96
Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Appl Microbiol Biotechnol (2008) 0.94
Protective efficacy induced by recombinant Clostridium difficile toxin fragments. Infect Immun (2013) 0.94
Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis. Appl Environ Microbiol (2004) 0.93
Growth, lipid accumulation, and fatty acid composition in obligate psychrophilic, facultative psychrophilic, and mesophilic yeasts. FEMS Microbiol Ecol (2009) 0.93
Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue. World J Gastroenterol (2006) 0.93
The impact of bacteriophages on probiotic bacteria and gut microbiota diversity. Genes Nutr (2010) 0.91
Quantitative detection of probiotic Bifidobacterium strains in bacterial mixtures by using real-time PCR. Syst Appl Microbiol (2003) 0.91
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. Proc Natl Acad Sci U S A (2013) 0.91
Fermentation of xylo-oligosaccharides by Bifidobacterium adolescentis DSMZ 18350: kinetics, metabolism, and β-xylosidase activities. Appl Microbiol Biotechnol (2012) 0.90
Substrate preference of Bifidobacterium adolescentis MB 239: compared growth on single and mixed carbohydrates. Appl Microbiol Biotechnol (2006) 0.89
Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis. Eur J Pharm Sci (2010) 0.88
Kinetics and metabolism of Bifidobacterium adolescentis MB 239 growing on glucose, galactose, lactose, and galactooligosaccharides. Appl Environ Microbiol (2007) 0.87
Getting lipids from glycerol: new perspectives on biotechnological exploitation of Candida freyschussii. Microb Cell Fact (2014) 0.87
In vitro comparison of the prebiotic effects of two inulin-type fructans. Anaerobe (2008) 0.87
Proteome profiles of vaginal fluids from women affected by bacterial vaginosis and healthy controls: outcomes of rifaximin treatment. J Antimicrob Chemother (2013) 0.87
Correlation of Atopobium vaginae Amount With Bacterial Vaginosis Markers. J Low Genit Tract Dis (2012) 0.86
Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate. Eur J Pharm Sci (2008) 0.86
Administration of folate-producing bifidobacteria enhances folate status in Wistar rats. J Nutr (2007) 0.86
Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer. Radiother Oncol (2012) 0.86
Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide. ACS Chem Biol (2012) 0.86
Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate. Vaccine (2010) 0.84
Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features. Int J Radiat Oncol Biol Phys (2010) 0.84
Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota. Antimicrob Agents Chemother (2012) 0.84
Effect of a Lactobacillus animalis strain on composition and metabolism of the intestinal microflora in adult dogs. Vet Microbiol (2007) 0.84
Role of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside. Appl Microbiol Biotechnol (2011) 0.83
Assessment of in-line near-infrared spectroscopy for continuous monitoring of fermentation processes. Biotechnol Prog (2003) 0.82
Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteria. Appl Microbiol Biotechnol (2013) 0.82
In vitro transformation of chlorogenic acid by human gut microbiota. Mol Nutr Food Res (2013) 0.82
Plasminogen-dependent proteolytic activity in Bifidobacterium lactis. Microbiology (2008) 0.81
Rapid method for screening enoate reductase activity in yeasts. J Microbiol Methods (2010) 0.81
Role of bifidobacteria in the hydrolysis of chlorogenic acid. Microbiologyopen (2014) 0.80
Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis. Int J Antimicrob Agents (2008) 0.80
Enoate reductases from non conventional yeasts: bioconversion, cloning, and functional expression in Saccharomyces cerevisiae. J Biotechnol (2011) 0.80
Paths to first treatment and duration of untreated illness in anorexia nervosa: are there differences according to age of onset? Eur Eat Disord Rev (2014) 0.79
Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach. World J Gastroenterol (2010) 0.79
Secretion of Kluyveromyces lactis Cu/Zn SOD: strategies for enhanced production. Appl Microbiol Biotechnol (2009) 0.78
Thermal adaptability of Kluyveromyces marxianus in recombinant protein production. Microb Cell Fact (2013) 0.77
Recombinant S. cerevisiae expressing Old Yellow Enzymes from non-conventional yeasts: an easy system for selective reduction of activated alkenes. Microb Cell Fact (2014) 0.77
The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer. Radiother Oncol (2011) 0.77
Fermentative production of superoxide dismutase with Kluyveromyces marxianus. J Ind Microbiol Biotechnol (2006) 0.76
Optimal conditions for stability of photoemission and freeze drying of two luminescent bacteria for use in a biosensor. Environ Toxicol Chem (2011) 0.76
Stability of recombinant plasmids on the continuous culture of Bifidobacterium animalis ATCC 27536. Biotechnol Bioeng (2003) 0.75
Role of Molecular Biology in Diagnosis and Characterization of Vulvo-Vaginitis in Clinical Practice. Gynecol Obstet Invest (2017) 0.75